MedTrace Logo

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

NCT01652495 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2014-09-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy and effects on the hypothalamus-pituitary-adrenal axis of a single intrabursal injection of two different types of corticosteroids (methylprednisolone and triamcinolone) in patients with calcific shoulder tendinopathy.

Conditions

Interventions

DRUG

methylprednisolone acetate

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of methylprednisolone acetate

DRUG

Triamcinolone Acetonide

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of triamcinolone acetonide

Sponsors & Collaborators

  • Azienda Ospedaliera San Giovanni Battista

    collaborator OTHER

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Milva Battaglia, MD · Istituti Ortopedici Rizzoli

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01652495 on ClinicalTrials.gov